financetom
Business
financetom
/
Business
/
CVS Health Q4 Adjusted Earnings Decline, Revenue Increases; 2025 Adjusted EPS Outlook Issued
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CVS Health Q4 Adjusted Earnings Decline, Revenue Increases; 2025 Adjusted EPS Outlook Issued
Feb 12, 2025 4:22 AM

06:48 AM EST, 02/12/2025 (MT Newswires) -- CVS Health ( CVS ) reported Q4 adjusted earnings Wednesday of $1.19 per diluted share, down from $2.12 a year earlier.

Analysts polled by FactSet expected $0.91.

Revenue for the quarter ended Dec. 31 was $97.71 billion, up from $93.81 billion a year earlier.

Analysts surveyed by FactSet expected $97.09 billion.

For 2025, the healthcare and pharmacy giant expects adjusted diluted EPS of $5.75 to $6.00. Analysts polled by FactSet expect non-GAAP EPS of $5.86.

Shares of the company were up more than 8% in Wednesday's premarket activity.

Price: 59.50, Change: +4.50, Percent Change: +8.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Standard Motor Products Enters Into $750 Million Credit Facility
Standard Motor Products Enters Into $750 Million Credit Facility
Sep 17, 2024
10:34 AM EDT, 09/17/2024 (MT Newswires) -- Standard Motor Products ( SMP ) said Tuesday it has secured a new five-year $750 million credit facility with JPMorgan Chase's ( JPM ) JPMorgan Chase Bank subsidiary serving as the agent, and a syndicate of lenders. The credit facility, which matures in September 2029, includes $310 million in term loans, a $440...
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Sep 17, 2024
10:31 AM EDT, 09/17/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Tuesday it signed a binding term sheet with Japanese pharmaceutical firm Nippon Shinyaku to commercialize and distribute Capricor's Duchenne muscular dystrophy treatment deramiocel in Europe. Capricor said the potential deal that the term sheet covers is similar to the existing commercialization and distribution agreements with Nippon Shinyaku...
CleanSpark Acquires New Bitcoin Mining Sites: What's Going On With The Mining Stock Tuesday?
CleanSpark Acquires New Bitcoin Mining Sites: What's Going On With The Mining Stock Tuesday?
Sep 17, 2024
CleanSpark Inc ( CLSK ) shares are trading higher Tuesday. The company announced the acquisition of two new mining sites, as well as the closing of its second site in Wyoming. What To Know: CleanSpark ( CLSK ) shares were up more than 3% in early trading Tuesday before pulling back. The Bitcoin (CRYPTO: BTC) mining company said it acquired...
Uber to roll out 'verified' rider badge, trip recording features in US
Uber to roll out 'verified' rider badge, trip recording features in US
Sep 17, 2024
(Reuters) - Uber is rolling out features that would allow its drivers to see verified badges on customer profiles and record trips on their smartphones instead of a dashcam, the ride-hailing firm said on Tuesday. This is expected to improve safety of drivers and comes against the backdrop of a 2021-22 safety report by Uber that said 31% of sexual...
Copyright 2023-2026 - www.financetom.com All Rights Reserved